登录 | 注册    关注公众号  
微信公众号
搜索
 >  Kits>DNA >OPA-R017

resDetect™ Pichia pastoris resDNA Quantiation Kit (qPCR)

For research use only.

背景(Background)

Residual host cell DNA refers to fragments of DNA from the host organism that are left behind after a biological process such as the production of a biopharmaceutical product or the cultivation of a cell line. This residual DNA can potentially contaminate the final product and affect its safety and efficacy. In the context of biopharmaceutical production, regulatory agencies such as the FDA and EMA have set limits on the amount of residual host cell DNA that is acceptable in a final product. These limits vary depending on the type of product and the route of administration, and residue host cell DNA quantitation kits are designed to ensure that the final product is safe for human use.

产品描述(Product Details)

Pichia pastoris resDNA Quantitation Kit is designed for quantitative detection of residual Pichia pastoris DNA in biopharmaceuticals (Antibodies, Vaccines, etc.). Based on real-time quantitative PCR (qPCR) method, this kit makes the detection of the residual DNA from Pichia pastoris rapid and reliable. The lower limit of quantitation is 3 fg/µL. All procedures are typically in less than 4 hours.

Use the kit after you extract host cell DNA from test samples. To achieve the best performances, resDNA Sample Preparation Kit Ⅱ(Magnetic Beads) (Cat. No. OPA-R024) is recommended for DNA extraction.

产品特性(Features)

  1. High sensitivity for optimal product safety: LLOD (1 fg/µL) for detection of residue host cell DNA
  2. High specificity: No cross-reactivity with unrelated DNA
  3. Validation: ICH Q2(R2) as Validation of Analytical Procedures
  4. High-quality: This kit is manufactured in GMP-like facility and alignment with the ISO 13485 standard.

应用说明(Application)

The kit is used for quantitative detection of residual Pichia pastoris DNA in biopharmaceuticals.

For use in quality control/manufacturing process only.

It is for research use only.

技术参数(Technical Specifications)

DNA Technical Specifications

使用提示(Attention)

If your experimental process requires sample preparation, please purchase and conduct the experiment using the sample preparation kits recommended in the table to ensure that the buffers used in both the sample preparation and resDNA detection are consistent.
DNA Attention

质量管理控制体系(QMS)

  1. 质量管理体系(ISO, GMP)
  2. 质量优势
  3. 质控流程
 

典型数据-Typical Data Please refer to DS document for the assay protocol.

DNA TYPICAL DATA

Figure 1. High sensitivity and broad dynamic range using the Pichia pastoris resDNA Quantitation Kit. (A) Typical analysis results obtained with Standard 1 (300 pg/μL) to 6 (3 fg/μL). (B) The standard curve of the 10-fold dilution series. PCR efficiency should be 90-110%.

DNA TYPICAL DATA

Figure 2. Assay specificity. Standard curves generated using 10-fold serial dilution of Pichia pastoris genomic DNA (included in the kit) in the presence of DNA (CHO, E. coli and HEK293).

 

组分(Materials Provided)

IDComponentsSize
OPA-R017-012×qPCR Master Mix1.0 mL×2
OPA-R017-02Pichia Primer & Probe Mix700 μL
OPA-R017-03Pichia DNA Control(3ng/μL)100 μL
OPA-R017-04Dilution Buffer1.5 mL×3
OPA-R017-05DNase/RNase-free Water1.0 mL

 
评论(0)
 
ACRO质量管理体系
 
 

前沿进展

Filter-Assisted ICP-MS Tumor Liquid Biopsy Enabled by Dual-Target-Regulated Functional DNA Nanospheres Cascade Amplification
Wu, Wang, Yan et al
Small Methods (2025)
Abstract: An ultrasensitive ICP-MS aptasensor is developed utilizing a label-free, simple filter membrane-assisted separation technique combined with nucleic acid signal amplification for the analysis of circulating tumor cells (CTCs) in lung cancer clinical samples. The approach is based on the high-affinity interaction between aptamers and PD-L1 and mucin 1, which are overexpressed on the cell surface, in conjunction with functional Y-DNA nanospheres and catalytic hairpin assembly amplifications, enabling the simultaneous detection of two proteins. Additionally, a four-armed nanostructure with significant spatial site resistance is self-assembled by introducing streptavidin with biotinylated-hairpin structures, improving the separation efficiency of the filter membrane. This structural design enables the effective isolation of biotin-T-Hg2+-T and biotin-C-Ag+-C from free Hg2+ and Ag+, facilitating highly sensitive dual-protein detection via ICP-MS. The limits of detection reached ag mL-1 levels for proteins and single-cell levels for A549 cells. CTCs are extracted from whole blood samples of lung cancer patients within 45 min through a simple centrifugation procedure. Quantification of CTCs is performed in 37 clinical samples, demonstrating results consistent with clinical diagnoses. The assay exhibits a specificity of 100% and a sensitivity of 94.5%.© 2025 Wiley‐VCH GmbH.
DNA Dual-Color Probes for Real-Time Monitoring of p21 mRNA and Bax mRNA during Apoptosis in Breast Cancer Cells
Wu, Tian, Zhang et al
ACS Appl Mater Interfaces (2025)
Abstract: Monitoring apoptosis in breast cancer cells is crucial for understanding the molecular mechanisms underlying breast cancer and evaluating the therapeutic effects of anticancer drugs. Real-time monitoring of p21 mRNA and Bax mRNA during apoptosis offers a valuable tool for assessing drug efficacy. Tetrahedral DNA frameworks (TDFs) are known for their ease of synthesis and multiple signal outputs. Leveraging these properties, this study developed DNA dual-color probes (DDCPs) for the real-time monitoring of apoptosis in breast cancer cells. In the presence of p21 and Bax mRNA, strand displacement reactions within the DDCPs restore Cy5 and FAM fluorescence signals, respectively. This strategy is consistent with the results of RT-qPCR studies. Moreover, the DDCPs allow for the specific investigation of apoptotic pathways in breast cancer cells influenced by different drugs by using distinct fluorescent signals for pathway differentiation. This method holds promise as a powerful tool for investigating apoptotic mechanisms in breast cancer cells, uncovering associated signaling pathways, and screening potential therapeutic drugs.
A Novel DNA-Platinum Nanoparticle Conjugation Method for Attomolar Detection and Quantitation of Nucleic Acids Using the Microbubbling Digital Assay
Jain, West, Ramjee et al
Anal Chem (2025)
Abstract: Platinum nanoparticles (PtNPs) hold promise for developing novel point-of-care diagnostic tools. This study focuses on the synthesis of single-stranded DNA-platinum nanoparticle (DNA-PtNP) conjugates used as detection probes for nucleic acids in an ultrasensitive and amplification-free microbubbling digital assay. Although significant research exists for synthesizing DNA-gold nanoparticle (AuNP) conjugates, methods for synthesizing stable nucleic acid-PtNP conjugates, especially for larger PtNPs (>50 nm), remain unreported. The instability and slow ligand exchange rate of PtNP colloidal solutions make this synthesis challenging, as conventional methods such as salt aging cause PtNP aggregation and require prolonged durations. This study evaluates the effect of factors such as incubation time, DNA length, salt concentration, pH, and surfactants on DNA loading and hybridization on PtNPs. These findings led to a novel DNA-PtNP conjugation method featuring a 30 min pH-mediated conjugation followed by a 30 min freezing at -20 °C. This conjugation approach is rapid, efficient, and sonication-free, resulting in high DNA loading and hybridization efficiency and stable conjugates. Using these conjugates in the microbubbling digital assay enables the assay to detect and quantify nucleic acids in the attomolar range. Using HCV RNA as an example, the limit of detection of the microbubbling digital assay was 0.68 aM (408 copies/ml or 68 IU/ml). Our findings can be extended to other bio/nano systems, using oligonucleotide-loaded platinum nanoparticles to develop novel molecular diagnostics.
Germline Whole-Exome Sequencing in Non-Smoker Lung Cancer Patients Reveals Pathogenic Variants in Lung Cancer Driver Genes
Carapezza, Minardi, Noci et al
Genes Chromosomes Cancer (2025) 64 (3), e70040
Abstract: Approximately 10%-15% of all lung cancers arise in non-smokers. Although there are no established aetiological factors, non-smokers with a family history of cancer have an increased risk of lung cancer, implying host genetic factors in lung cancer susceptibility. We sought to identify, in a cohort of 75 patients recruited before lung lobectomy, germline alterations with a strong association with lung cancer. Whole-exome sequencing was performed on genomic DNA from peripheral blood. Six resources were used to select pathogenic germline variants with strong clinical significance. In total, 33 pathogenic or likely pathogenic variants in 31 genes were identified. Of these, 13 were located in cancer-predisposing genes (nine were lung cancer drivers), most of which were involved in DNA repair mechanisms and diseases of metabolism. Among DNA repair-related genes, BRCA1 and BRCA2, and ATM have also been identified in other studies on non-smokers. Our results strongly support the hypothesis that a number of non-smoker lung cancer patients carry germline variants in cancer-predisposing genes, suggesting that lung cancer patients, particularly non-smokers, should be considered for germline molecular testing.© 2025 The Author(s). Genes, Chromosomes and Cancer published by Wiley Periodicals LLC.
Showing 1-4 of 1947708 papers.
Powered by BizGenius
 
 
货号/价格
文档
联系电话:
+86 400-682-2521(全国)
010-53681107(北京)
021-50850665(上海)
运输方式
订单邮箱:
order.cn@acrobiosystems.com
技术支持邮箱:
tech.cn@acrobiosystems.com
前沿进展
点击查看详细
相关产品
View All DNA View All PCR

消息提示

请输入您的联系方式,再点击提交!

确定